TRxADE HEALTH (MEDS) Stock Chart & Stock Price History $1.99 -0.04 (-1.97%) As of 07/25/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock TRxADE HEALTH Stock Price Performance The TRxADE HEALTH (MEDS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 77.81%, with a year-to-date return of -67.90%. In the past month, the stock has increased 112.72%, reflecting recent market activity. As of the latest close, TRxADE HEALTH traded at $1.99 with a market cap of $2.80 million and volume of 181,473 shares. Five years ago, the stock traded at a split-adjusted price of $105.90, representing a 98.12% decrease over that period. At the time, it had a market cap of $60.77 million and a volume of 2,137 shares. Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.97%1 Month Performance+112.72%3 Month Performance+110.72%Year-To-Date Performance-67.90%1 Year Performance-77.81%5 Year Performance-98.12% MEDS Stock Chart for Wednesday, July, 30, 2025 MEDS Chart by TradingView TRxADE HEALTH Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$1.99$1.99$2.04$1.90181,473 shs$2.80 million07/28/2025$1.99$1.99$2.04$1.90181,473 shs$2.80 million07/25/2025$2.20$2.03-7.73%$2.17$2.02203,625 shs$10.67 million07/24/2025$2.20$2.20$2.22$2.11231,182 shs$3.09 million07/23/2025$2.14$2.20+2.80%$2.22$2.11231,182 shs$3.09 million07/22/2025$2.12$2.14+1.18%$2.15$2.00247,221 shs$3.01 million07/21/2025$2.12$2.12$2.22$2.05357,882 shs$2.97 million07/18/2025$2.05$2.08+1.46%$2.08$1.87358,366 shs$2.92 million07/17/2025$1.71$2.05+19.88%$2.10$1.73405,421 shs$2.88 million07/16/2025$1.65$1.71+3.64%$1.95$1.61731,585 shs$2.40 million Get the Latest News and Ratings for MEDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$1.59$1.65+3.77%$1.65$1.53164,325 shs$2.32 million07/14/2025$1.59$1.59$1.67$1.5696,024 shs$2.24 million07/11/2025$1.60$1.64+2.50%$1.67$1.55168,138 shs$2.31 million07/10/2025$1.61$1.60-0.62%$1.66$1.55145,843 shs$2.25 million07/09/2025$1.62$1.61-0.62%$1.66$1.55238,829 shs$2.26 million07/08/2025$1.45$1.62+11.72%$1.67$1.43415,269 shs$2.28 million07/07/2025$1.45$1.45$1.50$1.39173,670 shs$2.04 million07/04/2025$1.46$1.45-0.68%$1.50$1.39173,670 shs$2.04 million07/03/2025$1.29$1.46+13.18%$1.58$1.26513,083 shs$2.05 million07/02/2025$1.04$1.29+24.04%$1.29$1.01255,702 shs$1.81 million07/01/2025$0.94$1.04+11.17%$1.04$0.95116,368 shs$1.46 million06/30/2025$0.94$0.94$0.97$0.9379,197 shs$1.32 million Related Companies Educational Development Stock Chart SAG Stock Chart HWH International Stock Chart Euro Tech Stock Chart PTL Stock Chart F45 Training Stock Chart Universal Security Instruments Stock Chart Safe & Green Stock Chart Greenlane Stock Chart urban-gro Stock Chart Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MEDS) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
